Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

Compare

0.7547

+0.0427 (6.00%)

At close: Feb 6, 2026, 4:00 PM EST

0.7460

-0.0087 (-1.15%)

After-hours: Feb 6, 2026, 7:59 PM EST

Citius Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	4.25	3.25	26.48	41.71	70.07
Cash & Short-Term Investments	4.25	3.25	26.48	41.71	70.07
Cash Growth	30.76%	-87.72%	-36.51%	-40.47%	405.59%
Inventory	22.29	8.27	-	-	-
Prepaid Expenses	1.4	2.7	7.89	2.85	2.74
Total Current Assets	27.93	14.22	34.37	44.56	72.81
Property, Plant & Equipment	0.82	0.25	0.46	0.65	0.83
Goodwill	9.35	9.35	9.35	9.35	9.35
Other Intangible Assets	92.8	92.8	59.4	59.4	59.4
Other Long-Term Assets	0.04	0.04	0.04	0.04	0.04
Total Assets	130.94	116.65	103.61	114	142.43
Accounts Payable	13.69	4.93	2.93	1.17	1.28
Accrued Expenses	7.48	2.25	2.63	3.17	2.53
Short-Term Debt	1	-	-	-	-
Current Portion of Leases	0.09	0.24	0.22	0.2	0.18
Other Current Liabilities	22.65	28.4	-	-	-
Total Current Liabilities	44.91	35.81	5.78	4.53	3.98
Long-Term Leases	0.72	0.02	0.26	0.48	0.68
Long-Term Deferred Tax Liabilities	7.77	6.71	6.14	5.56	4.99
Total Liabilities	53.41	42.55	12.18	10.57	9.65
Common Stock	0.02	0.01	0.01	0.15	0.15
Additional Paid-In Capital	306.34	271.44	253.06	232.37	228.08
Retained Earnings	-238.8	-201.37	-162.23	-129.69	-96.05
Total Common Equity	67.55	70.08	90.83	102.83	132.18
Minority Interest	9.98	4.02	0.6	0.6	0.6
Shareholders' Equity	77.53	74.1	91.43	103.43	132.78
Total Liabilities & Equity	130.94	116.65	103.61	114	142.43
Total Debt	1.81	0.26	0.48	0.68	0.86
Net Cash (Debt)	2.44	2.99	26	41.03	69.22
Net Cash Growth	-18.40%	-88.50%	-36.64%	-40.72%	453.40%
Net Cash Per Share	0.22	0.44	4.30	7.02	15.93
Filing Date Shares Outstanding	20.76	7.73	6.36	5.85	5.84
Total Common Shares Outstanding	18.07	7.25	6.35	5.85	5.84
Working Capital	-16.98	-21.59	28.59	40.03	68.83
Book Value Per Share	3.74	9.67	14.29	17.58	22.64
Tangible Book Value	-34.6	-32.07	22.08	34.08	63.44
Tangible Book Value Per Share	-1.91	-4.43	3.48	5.83	10.86

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q